154 related articles for article (PubMed ID: 6189972)
21. A simple method to diagnose adrenoleukodystrophy using a dried blood spot on filter paper.
Nishio H; Kodama S; Yokoyama S; Matsuo T; Mio T; Sumino K
Clin Chim Acta; 1986 Aug; 159(1):77-82. PubMed ID: 3757269
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
Tsuji S; Sano-Kawamura T; Ariga T; Miyatake T
J Neurol Sci; 1985 Dec; 71(2-3):359-67. PubMed ID: 4087029
[TBL] [Abstract][Full Text] [Related]
23. Determination of C20-C30 fatty acids by reversed-phase chromatographic techniques: an efficient method to quantitate minor fatty acids in serum of patients with adrenoleukodystrophy.
Alberghina M; Fiumara A; Pavone L; Giuffrida AM
Neurochem Res; 1984 Dec; 9(12):1719-27. PubMed ID: 6531070
[TBL] [Abstract][Full Text] [Related]
24. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
[TBL] [Abstract][Full Text] [Related]
25. Very long chain fatty acids in genetic peroxisomal disease fibroblasts: differences between the cerebro-hepato-renal (Zellweger) syndrome and adrenoleukodystrophy variants.
Molzer B; Korschinsky M; Bernheimer H; Schmid R; Wolf C; Roscher A
Clin Chim Acta; 1986 Nov; 161(1):81-90. PubMed ID: 3815856
[TBL] [Abstract][Full Text] [Related]
26. Neonatal-onset adrenoleukodystrophy in a girl.
Haas JE; Johnson ES; Farrell DL
Ann Neurol; 1982 Nov; 12(5):449-57. PubMed ID: 6295256
[TBL] [Abstract][Full Text] [Related]
27. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
[TBL] [Abstract][Full Text] [Related]
28. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid abnormality in adrenoleukodystrophy.
Igarashi M; Schaumburg HH; Powers J; Kishmoto Y; Kolodny E; Suzuki K
J Neurochem; 1976 Apr; 26(4):851-60. PubMed ID: 965973
[No Abstract] [Full Text] [Related]
30. Impaired ability of peroxisomes to activate very-long-chain fatty acids in X-linked adrenoleukodystrophy.
Wanders RJ; van Roermund CW; Schutgens RB; van den Bosch H; Tager JM
Lancet; 1988 Jul; 2(8603):170. PubMed ID: 2899227
[No Abstract] [Full Text] [Related]
31. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.
Brown FR; McAdams AJ; Cummins JW; Konkol R; Singh I; Moser AB; Moser HW
Johns Hopkins Med J; 1982 Dec; 151(6):344-51. PubMed ID: 7176294
[No Abstract] [Full Text] [Related]
32. Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination.
Theda C; Moser AB; Powers JM; Moser HW
J Neurol Sci; 1992 Jul; 110(1-2):195-204. PubMed ID: 1506859
[TBL] [Abstract][Full Text] [Related]
33. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
34. Gas chromatography-electron impact-mass spectrometry (GC-EI-MS) analysis of saturated fatty acid compositions in formalin-fixed human tissues.
Yamamoto H; Yamamoto T; Konno H; Tezuka F; Iwasaki Y
J Neurol Sci; 1987 Jan; 77(1):1-10. PubMed ID: 3806133
[TBL] [Abstract][Full Text] [Related]
35. Childhood form of adrenoleukodystrophy in the sucking infant.
Kodama S; Nishio H; Yokoyama S; Matsuo T; Yamano T; Shimada M
Pediatr Neurosci; 1985-1986; 12(4-5):252-6. PubMed ID: 3843624
[TBL] [Abstract][Full Text] [Related]
36. [Adrenoleukodystrophy].
Miyatake T
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):821-3. PubMed ID: 3270899
[No Abstract] [Full Text] [Related]
37. Bone marrow transplant in adrenoleukodystrophy.
Moser HW; Tutschka PJ; Brown FR; Moser AE; Yeager AM; Singh I; Mark SA; Kumar AA; McDonnell JM; White CL
Neurology; 1984 Nov; 34(11):1410-7. PubMed ID: 6387532
[TBL] [Abstract][Full Text] [Related]
38. Effects of subperineurial injections of very-long-chain and medium-chain fatty acids into rat sciatic nerve.
Sacktor NC; Griffin J; Moser AB; Moser HW
Neurochem Pathol; 1986 Aug; 5(1):71-83. PubMed ID: 3561895
[TBL] [Abstract][Full Text] [Related]
39. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
[TBL] [Abstract][Full Text] [Related]
40. Adrenoleukodystrophy: from bedside to molecular biology.
Moser HW
J Child Neurol; 1987 Apr; 2(2):140-50. PubMed ID: 3598142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
